In a filing, Phathom Pharmaceuticals Inc revealed its Director Topper James N acquired Company’s shares for reported $14609.0 on May 21 ’25. In the deal valued at $3.86 per share,3,780 shares were bought. As a result of this transaction, Topper James N now holds 59,403 shares worth roughly $0.25 million.
Then, Topper James N bought 6,300 shares, generating $20,919 in total proceeds. Upon buying the shares at $3.32, the Director now owns 55,623 shares.
Before that, Topper James N bought 1,120 shares. Phathom Pharmaceuticals Inc shares valued at $3,543 were divested by the Director at a price of $3.16 per share. As a result of the transaction, Topper James N now holds 49,323 shares, worth roughly $0.21 million.
Cantor Fitzgerald initiated its Phathom Pharmaceuticals Inc [PHAT] rating to an Overweight in a research note published on February 14, 2025; the price target was $23. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Needham also remained covering PHAT and reiterated its “Buy” recommendation on January 05, 2024. H.C. Wainwright started covering the stock on August 09, 2023. It rated PHAT as “a Buy”.
Price Performance Review of PHAT
On Friday, Phathom Pharmaceuticals Inc [NASDAQ:PHAT] saw its stock fall -1.39% to $4.25. Over the last five days, the stock has gained 0.47%. Phathom Pharmaceuticals Inc shares have fallen nearly -47.66% since the year began. Nevertheless, the stocks have fallen -58.70% over the past one year. While a 52-week high of $19.71 was reached on 01/02/25, a 52-week low of $2.21 was recorded on 05/08/25. SMA at 50 days reached $4.38, while 200 days put it at $9.40.
Levels Of Support And Resistance For PHAT Stock
The 24-hour chart illustrates a support level at 4.10, which if violated will result in even more drops to 3.95. On the upside, there is a resistance level at 4.35. A further resistance level may holdings at 4.44. The Relative Strength Index (RSI) on the 14-day chart is 54.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.37%. Stochastics %K at 86.44% indicates the stock is a selling.
